CJC-1295 is a growth hormone-releasing hormone (GHRH) analog available in two forms: with DAC (Drug Affinity Complex) for extended half-life, and without DAC (MOD GRF 1-29) for more pulsatile release. It's one of the most established peptides for growth hormone research.
Stimulates the pituitary gland to release growth hormone by mimicking natural GHRH signaling. The DAC version provides sustained release while the non-DAC version allows more natural pulsatile patterns.
Peptides that stimulate or support growth hormone release, including GHRH analogs, GHRPs, and direct GH compounds for muscle, recovery, and anti-aging research.
This peptide is commonly available through U.S. compounding pharmacies with a valid prescription. These facilities are regulated and offer pharmaceutical-grade products.
Browse our verified directory of pharmacies, telehealth providers, and research vendors.
Browse ProvidersThe information provided about CJC-1295 is for educational and research purposes only. This content is not intended as medical advice, diagnosis, or treatment recommendation.CJC-1295 is a research compound and may not be approved for human use. Always consult with a qualified healthcare provider before considering any peptide therapy. The Peptide List does not sell peptides or provide medical services.
This website is for informational purposes only and does not constitute medical advice. Consult a licensed physician before using any peptides. Provider listings do not constitute endorsements. None of the statements on this site have been evaluated by the FDA.